Vnitr Lek 2016, 62(Suppl 3):82-86

Central Thyroid Disorders

Michal Kršek
II. interní klinika 3. LF UK a FN Královské Vinohrady, Praha

Vast majority of thyroid function disturbances have primary (peripheral) etiology due to thyroid gland disorders. Rarely, dysfunction of central regulatory structures, hypothalamus and pituitary, can be a cause of both, hyperthyroidism and hypothyroidism. Despite being very rare, it is important to be aware of them not to misdiagnose their etiology. Early and correct etiological diagnosis is necessary for proper cure and decrease of morbidity and mortality of affected patients. Present review article summarizes basics and specific features of central disturbances of thyroid function, their clinical signs, diagnosis, differential diagnosis and treatment.

Keywords: hypothalamus; hyperthyroidism; hypothyroidism; pituitary; thyrotropinoma

Received: July 16, 2016; Accepted: August 19, 2016; Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kršek M. Central Thyroid Disorders. Vnitr Lek. 2016;62(Supplementum 3):82-86.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jailer JW, Holub DA. Remission of Graves' disease following radiotherapy of a pituitary neoplasm. Am J Med 1960; 28: 497-500. Go to original source... Go to PubMed...
    2. Hamilton CR Jr, Adams LC, Maloof F. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma. N Engl J Med 1970; 283(20): 1077-1080. Go to original source... Go to PubMed...
    3. Beck-Peccoz P, Brucker-Davis F, Persani L et al. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17(6): 610-638. Go to original source...
    4. Önnestam L, Berinder K, Burman P et al. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 2013; 98(2): 626-635. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2012-3362>. Go to original source... Go to PubMed...
    5. Beck-Peccoz P, Persani L, Mannavola D et al. Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab 2009; 23(5): 597-606. Dostupné z DOI: <http://dx.doi.org/10.1016/j.beem.2009.05.006>. Go to original source... Go to PubMed...
    6. Socin HV, Chanson P, Delemer B et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 2003; 148(4): 433-442. Go to original source... Go to PubMed...
    7. Abs R, Stevenaert A, Beckers A. Autonomously functioning thyroid nodules in a patient with thyrotropin secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol 1994; 131(4): 355-358. Go to original source... Go to PubMed...
    8. Hana V, Seidl Z, Vaneckova M et al. Randomly discovered enlargement in the region of sella turcica. Vnitř Lék 2007; 53(7-8): 816-820. Go to PubMed...
    9. Webster J, Peters JR, John R et al. Pituitary stone: two cases of densely calcified thyrotropin-secreting pituitary adenomas. Clin Endocrinol (Oxf) 1994; 40(1): 137-143. Go to original source... Go to PubMed...
    10. Beck-Peccoz P, Persani L. Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 1994; 131(4): 331-340. Go to original source... Go to PubMed...
    11. Dumitrescu AM, Retetoff S. The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta 2013; 1830(7): 3987-4003. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bbagen.2012.08.005>. Go to original source... Go to PubMed...
    12. Beck-Peccoz P, Persani L, Lania A. Thyrotropin secreting pituitary adenomas. In: De Groot LJ, Beck-Peccoz P, Chrousos G et al (eds). Endotext (Internet). South Darmot MA, USA, MD Text.com. Inc., 2000. Dostupné z WWW: <http://www.ncbi.nlm.nih.gov/books/NBK278943>.
    13. Losa M, Mortini P, Franzin A et al. Surgical management of thyrotropin-secreting pituitary adenomas. Pituitary 1999; 2(2): 127-131. Go to original source... Go to PubMed...
    14. Mannavola D, Persani L, Vannucchi G et al. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) 2005; 62(2): 176-181. Go to original source... Go to PubMed...
    15. Lania A, Persani L, Beck-Peccoz P. Central hypothyroidism. Pituitary 2008; 11(2): 181-186. Dostupné z DOI: <http://dx.doi.org/10.1007/s11102-008-0122-6>. Go to original source... Go to PubMed...
    16. Sherman SI, Gopal J, Haugen BR et al. Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 1999; 340(14): 1075-1079. Go to original source... Go to PubMed...
    17. Dattani MT, Robinson IC. The molecular basis for developmental disorders of the pituitary gland. Clin Genet 2000; 57(5): 337-346. Go to original source... Go to PubMed...
    18. Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002; 23(4): 431-442. Go to original source... Go to PubMed...
    19. Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13(1): 3-126. Go to original source... Go to PubMed...
    20. Mehta A, Hindmarsh PC, Stanhope RG et al. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocriol Metab 2003; 88(12): 5696-5703. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.